Top Ranked Income Stocks to Buy for March 19th

Zacks Equity Research Published on March 19, 2020

Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 19th:

Costamare Inc. (CMRE - Free Report) : This owner and charterer of containerships has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.9% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 11.1%, compared with the industry average of 0%. Its five-year average dividend yield is 7.8%.

DHT Holdings, Inc. (DHT - Free Report) : This owner and operator of crude oil tankers has witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.4% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 24%, compared with the industry average of 0%. Its five-year average dividend yield is 6.3%.

AGNC Investment Corp. (AGNC - Free Report) : This real estate investment trust has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 19.7%, compared with the industry average of 11.9%. Its five-year average dividend yield is 11.8%.

ARMOUR Residential REIT, Inc. (ARR - Free Report) : This company that invests in residential mortgage backed securities has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 28.6%, compared with the industry average of 11.9%. Its five-year average dividend yield is 12.6%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.